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Mechanism of capsaicin receptor TRPV1-mediated toxicity in pain-sensing neurons
focusing on the effects of Na+/Ca2+ ﬂuxes and the Ca2+-binding protein calretinin
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Transient receptor potential vanilloid subtype 1 (TRPV1) receptor is a pain-sensing, ligand-gated, non-
selective cation channel expressed in peripheral sensory neurons. Prolonged activation of TRPV1 by capsaicin
leads to cell swelling and formation of membrane blebs in rat dorsal root ganglion (DRG) neurons. Similar re-
sults were obtained in NIH3T3 ﬁbroblast cells stably expressing TRPV1. Here, we assessed the contribution of
Ca2+ and Na+ ions to TRPV1-mediated changes. Cell swelling was caused by a substantial inﬂux of extracel-
lular Na+ via TRPV1 channels, causing concomitant transport of water. In the absence of extracellular Na+,
the membrane blebbing was completely inhibited, but Ca2+ inﬂux did not change under these conditions.
Na+ inﬂux was modulated by the intracellular Ca2+ concentration ([Ca2+]i). Elevation of [Ca2+]i by
ionomycin sensitized/activated TRPV1 channels causing cell swelling in TRPV1-positive cells. In the absence
of extracellular Ca2+, capsaicin caused only little increase in [Ca2+]i indicating that the increase in [Ca
2+]i ob-
served after capsaicin application is derived essentially from extracellular Ca2+ and not from internal Ca2+
stores. In the absence of extracellular Ca2+ also the process of cell swelling was considerably slower.
Calretinin is a Ca2+ buffer protein, which is expressed in a subset of TRPV1-positive neurons. Calretinin de-
creased the amplitude, but slowed down the decay of Ca2+ signals evoked by ionomycin. Cells co-expressing
TRPV1 and calretinin were less sensitive to TRPV1-mediated, capsaicin-induced volume increases. In
TRPV1-expressing NIH3T3 cells, calretinin decreased the capsaicin-induced Ca2+ and Na+ inﬂux. Swelling
and formation of membrane blebs resulted in impaired plasma membrane integrity ﬁnally leading to cell
death. Our results hint towards a mechanistic explanation for the apoptosis-independent capsaicin-evoked
neuronal loss and additionally reveal a protective effect of calretinin; we propose that the Ca2+-buffering ca-
pacity of calretinin reduces the susceptibility of calretinin-expressing DRG neurons against cell swelling/
death caused by overstimulation of TRPV1 channels. This article is part of a Special Issue entitled:12th European
Symposium on Calcium.
1. Introduction
Transient receptor potential vanilloid type 1 (TRPV1) is one of the
main pain-sensing receptors in sensory neurons [1,2]. TRPV1 forms a
homo-tetramer with six trans-membrane segments per monomer;
the N- and C-termini are intracellular. The cation pore is formed by
P-loops of the four monomers and the P loop is the region between
trans-membrane domains 5 and 6 [3]. When opened, both Na+ and
Ca2+ ions enter the cytoplasmic compartment through TRPV1 channels
localized in the plasmamembrane [4]. Functionally active TRPV1 chan-
nels are also present in the ERmembrane (TRPV1ER), depleting intracel-
lular Ca2+ stores upon activation [5,6]. However, the sensitivity of
TRPV1ER to exogenous activators is lower than that of the plasma
membrane-embedded TRPV1 [7]. The channel can be activated by ele-
vated temperature (>43 °C) [4], both acidic and basic pH [8], or by
exo- and endovanilloids such as capsaicin (CAPS), resiniferatoxin
(RTX) [4], N-arachidonoyl-dopamin [9] or anandamide [10]. On the
contrary, TRPV1 is blocked with the channel blocker, Ruthenium Red
(RuRed) [11] and with competitive antagonists such as capsazepine
[12]. In the past, TRPV1 expression was assumed to be selective for
pain-sensing sensory neurons [13]. However, TRPV1 expression was
detected in various organs including brain, kidney, lung, testis, pancreas,
spleen, liver, stomach, skin, muscle and in cell lines derived from those
[14–16]. Interestingly, TRPV1 overstimulation leading to cytotoxicity
was only reported for neurons suggesting that either I) expression levels
of TRPV1 in non-neuronal tissues are low, II) neurons are particularly vul-
nerable or III) the physiological function of the TRPV1 channel is different
in various organs [17]. One caveat of the above mentioned studies is that
the authors did not consider that the samples used for the identiﬁcation
of TRPV1 might be “contaminated” with neuronal TRPV1-positive C and
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Aδ ﬁbers that enmesh all internal organs. In addition, discordant results
were obtained with two probably non-speciﬁc antibodies against
TRPV1 resulting in different expression patterns, e.g. in the skin [18,19].
In line with the above concerns, Cre-recombinase expression driven by
the TRPV1 promoter was mostly restricted to peripheral neurons in
transgenic mice [20].
Depending on the concentration applied and the exposure time,
TRPV1 agonists cause either desensitization [21] or selective degener-
ation of a distinct population of primary sensory neurons involved in
the mediation of pain [22]. Systemic administration of CAPS results in
the death of approximately 50% of sensory neurons in rat neonates
[13] and in a loss of approximately 17% in adult rats [23]. RTX, an
ultrapotent CAPS analogue, almost completely eliminates TRPV1-
expressing afferent neurons in adult rats, when applied systemically
[24]. Thus, selective ablation of pain-sensing neurons by administra-
tion of TRPV1 agonists may be effective in chronic pain treatment
[25]; topical CAPS formulations have already been used for pain
management [26]. The intrathecal administration of RTX went into a
clinical trial to treat severe cancer-mediated pain [27]. However, the
mechanisms by which TRPV1 agonists exert their cyto-/neuro-toxic
effects are not fully understood.
Calretinin (CR) is a cytosolic Ca2+ buffer protein from the large
family of EF-hand proteins, characterized by fast Ca2+-binding kinet-
ics [28] and may have additional functions, possibly as a Ca2+ sensor
[29]. CR is expressed in speciﬁc populations of neurons in the central
and peripheral nervous systems [30] and in certain cancer cells [31,32].
In neurons, CR was proposed to be implicated in neuroprotection.
CR-expressing cortical neurons are selectively resistant to excitotoxicity
in vitro [33] and ectopic CR expression delays the onset of cell death
in glutamate-sensitive P19 cells [34] and protects N18-RE105
neuroblastoma-retina cells from glutamate-induced excitotoxicity
[35]. In this study, we set out to investigate whether CR also has a pro-
tective effect against CAPS-induced, TRPV1-mediated “neurotoxicity.”
Beforehand we elaborated on the mechanisms of CAPS-induced cell
death in an in vitro model system using TRPV1-expressing ﬁbroblasts
(NIH3T3). Activation of the TRPV1 channel led to entry of Ca2+ and
mostly Na+, the latter causing water inﬂux and associated volume in-
crease in TRPV1-expresing cells. The rapid volume increase caused a
proportion of cells to lose plasmamembrane integrity and to die by a ne-
crotic, caspase-3/7-independent mechanism. Entry of Ca2+ via plasma
membrane TRPV1 channels increased the effect on volume increase
and cell death and the presence of CR attenuated the CAPS-mediated ef-
fects and consequently prevented/delayed cell death.
2. Materials and methods
2.1. Reagents
Thapsigargin, ionomycin (IONO), N-methyl-D-glucamine (NMDG)
and rat nerve growth factor were purchased from Sigma Aldrich
(St. Louis, MO, USA). Capsaicin (CAPS) and Ruthenium Red (RuRed)
were purchased from Tocris Bioscience (Bristol, UK). Fluo-3-AM,
FuraRed-AM, calcein-AM, CoroNa-Green-AM and pluronic acid were
from Invitrogen (Carlsbad, CA, USA).
2.2. Cell cultures and plasmids
NIH3T3 cells were grown in RPMI 1640 medium (Invitrogen)
supplemented with 10% fetal calf serum, 100 U/ml penicillin-
streptomycin (PEN-STREP). TRPV1-expressing NIH3T3 cells were
a kind gift from Dr. Zoltan Olah, Szeged, BRC. In those cells, the
metallothionein promoter is used to drive the expression of full-
length rat TRPV1 with a short 12 amino acid ε-tag [5]. This promot-
er is slightly leaky. Without any induction, it provides a stable,
permanent expression of TRPV1 protein [5]. All cultures were
maintained in a humidiﬁed atmosphere at 37 °C and 5% CO2. For
the generation of a NIH3T3 and TRPV1/NIH3T3 cell line stably ex-
pressing a fusion protein termed eGFP-CR consisting of the en-
hanced green ﬂuorescent protein (eGFP) as the N-terminal part
and full-length human calretinin as the C-terminal part, the retro-
viral expression vector pLVTHM (Addgene plasmid 12247 [36])
was used. The GFP cassette in pLVTHM was replaced with the
eGFP-CR cDNA (B. Schwaller and J. Antonov, unpublished). Brieﬂy,
the eGFP-CR insert was synthesized by PCR using the primers PmeI-
eGFP (5′-GTTTAAACCGCCACCATGGTGAGCAAGGGC-3′) and SpeI-CR
(5′-ACTAGTTTACATGGGGGGCTCGCTGCA3′) using the plasmid pEGFP-
CR as template. The PCR fragment was subcloned into pGEM-T-easy
(Promega). pGEM-T-easy was digested with PmeI and SpeI and the
PCR amplicon inserted into the unique sites of the pLVTHM to produce
the ﬁnal pLVTH-eGFP-CR. The CMV-mRFP-CR plasmid coding for the
monomeric red ﬂuorescent protein (mRFP) was produced by inserting
the CR sequence into the pDsRed-Monomer-C1 plasmid (Clontech,
Mountain View, CA). Brieﬂy, HindIII and KpnI restriction endonuclease
sites were incorporated into the CR PCR fragment ampliﬁed from
pRSV-CR [34] using the forward 5′-GAGAAAGCTTTAGCTGGCCCGCAG
CAGC-3′ and reverse 5′-GAGAGGTACCTTACATGGGGGGCTCGCTGCA-3′
primers, respectively. After digesting the PCR fragment with these
enzymes, the size-separated DNA insert was ligated in pDsRed-
Monomer-C1 at the compatible HindIII and KpnI sites. The mRFP-CR-
expressing NIH3T3 cells were generated by transient transfection
using the TransIT®-2020 transfection reagent (Mirus Bio, Madison, WI,
USA) following the manufacturer's instructions. All plasmids were
veriﬁed by DNA sequencing. Lentivirus was produced by the calcium
phosphate transfection method using HEK293T cells and three
plasmids: expression plasmid (pLVTHM-eGFP-CR), envelope plas-
mid pMD2G-VSVG (Addgene plasmid 12259) and packaging plasmid
(pCMV-dR8.91), a kind gift from Prof. D. Trono (EPFL, Lausanne). Viral
supernatants were collected after 48 h and 72 h, ﬁltered, aliquoted
and frozen at −80 °C [37]. After infection of NIH3T3, HeLa or TRPV1/
NIH3T3 cells, clones showing high ﬂuorescence intensity, i.e. high pro-
tein expression levels, were selected for further experiments.
2.3. Primary DRG cultures
DRG primary cultures were prepared from embryonic rats (E15).
Embryos were removed from the uterus and placed in Petri dishes
containing Krebs-Ringer buffer (in mM: 119 NaCl, 4.7 KCl, 2.5 CaCl2,
1.2. MgSO4, 1.2 KH2PO4, 25 NaHCO3, 2 glucose; pH 7.4). The cords
were dissected and DRGs were removed. The tissue was digested in
0.05% trypsin at 37 °C for 10 min and dissociated cell cultures were
maintained in DMEM containing 5% horse serum and 100 ng/ml
nerve growth factor to promote neuronal survival and differentiation.
After 2 days in vitro (DIV2) primary DRG cultures were analyzed
using confocal microscopy (Leica TCS SP5).
2.4. Cobalt histochemistry
CAPS-induced activation of plasmalemmal TRPV1 was assessed by
cobalt uptake. Cells seeded on glass coverslips at approximately
50% conﬂuence were washed with physiological salt solution
(0.9% NaCl) and then incubated for 10 min in the same solution
containing 5 mM CoCl2 and one of the following substances: 1)
no additive (control); 2) CAPS (5 μM); 3) IONO (5 μM); 4) CAPS
(5 μM) and Ruthenium Red (20 μM). Cells were washed 3-times
with physiological salt solution. Cobalt taken up by activated TRPV1
channels was precipitated by adding a 2.5% β-mercaptoethanol solution
in physiological salt solution for 5 min. Cells were ﬁxed in 4% parafor-
maldehyde solution and mounted. Pictures from the slides with cobalt
precipitate were taken with a light microscope DM RBE (Leica, Wetzlar,
Germany).
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2.5. Calcium imaging
Cells grown on collagen-coated glass bottom 35 mm dishes
(MatTek Corp., Ashland, MA) were loaded with the cell permeable
acetoxymethyl (AM)-ester form of the indicator dyes. The following
dyes were used: for Ca2+, Fluo-3 (3 μM) and FuraRed (5 μM)
(Invitrogen) diluted in culture medium for 1 h at 37 °C, for Na+,
CoroNa Green (10 μM) diluted in Krebs buffer for 30 min at 37 °C.
Pluronic acid (0.01%) was added to facilitate dye uptake. The buffer
solution (DPBS) used for Ca2+ imaging experiments contained
(in mM): NaCl 138, Na2HPO4 8, CaCl2 2, MgCl2 0.5, KCl 2.7,
KH2PO4 1.6, pH 7.4. In NMDG solutions, NaCl and Na2HPO4 were
replaced with equimolar N-methyl-D-glucamine (NMDG). In low
Ca2+ solution, CaCl2 was replaced with equimolar NaCl. We used
an inverted confocal microscope DMI6000 integrated to a Leica
TCS-SP5 workstation or an inverted ﬂuorescence microscope
DMI6000B (Leica) to examine changes of either [Ca2+]i or [Na+]i.
For the ratiometric Ca2+ measurements, cells were simultaneously
loaded with Fluo-3 and FuraRed. The 488-nm wavelength was
used to illuminate the cells. At the confocal microscope, ﬂuores-
cence emission was recorded at 505–550 nm (Fluo-3, CoroNa
Green) and 665 to 685 nm (FuraRed). Fluo-3/FuraRed ratio images
were calculated by dividing pixel values of Fluo-3 ﬂuorescence in-
tensity by pixel values of FuraRed ﬂuorescence intensity. At the
inverted ﬂuorescence microscope the additional Leica ﬁlters were
used: L5 for GFP, TX2 for FuraRed. Recordings were performed at
room temperature (22 °C), since pharmacological properties of
TRPV1 with respect to CAPS are not signiﬁcantly different from
the ones at 37 °C [17]. The drugs were added to the above-
mentioned solutions either by pipette or an Octaﬂow system
(ALA Scientiﬁc Instruments, Farmingdale, USA) and remained in
the solution until the end of the experiments. Fluorescence images
for either [Ca2+]i or [Na+]i measurements and transmitted images
for monitoring cell volume changes were collected simultaneously.
About 95–99% of the TRPV1/NIH3T3 cells and about 75–85% of
eGFP-CR/TRPV1/NIH3T3 cells responded to CAPS. Only these cells
were chosen for data analysis. Circular-shaped regions of interest
(ROI) were placed inside the cytoplasmic area of cells. The ﬂuorescence
values were calculated after background subtraction (ﬂuorescence in-
tensity of regionswithout cells). Fluorescence intensity valueswere nor-
malized in each experiment to the averaged basal value measured
during the non-treated period. Bleaching correction was carried out,
when the baseline was not stable. The LAS-AF (Leica) and Prism3
(GraphPad Software, Inc., San Diego, CA) software were used for data
analysis.
2.6. Cell volume estimation
Cell volumes were measured using two methods: the image anal-
ysis [38] and ﬂuorescence analysis [39] methods. The image analysis
technique allows to following the changes, both in the cell morphol-
ogy and [Ca2+]i. In this case the transmitted images were evaluated.
Cell borders were traced on the monitor with the use of the mouse.
The surface area of traced regions was determined by the image anal-
ysis software ImageJ. The relative cell volume changes were deter-
mined by the following relationship:
V tð Þ
V 0ð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S tð Þð Þ3
q
=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S 0ð Þð Þ3
q
where V(t) is the cell volume at time point t; V(0) is the cell volume
before treatment; S(t) is the surface area at time point t; S(0) is the
surface area before treatment.
The ﬂuorescence cell volume measurement is based on the dilu-
tion of the dye calcein. Calcein is a ﬂuorescent dye that is not sensitive
to the changes in either [Ca2+]i or [Na+]i at physiological pH. Cells
were loaded with 2 μM calcein-AM in cell medium at 37 °C for
30 min. Excitation was performed at 488 nm, and the emitted ﬂuo-
rescence was measured at 517 nm. The relative cell volume changes
were determined by the following equation:
V tð Þ
V 0ð Þ ¼ F 0ð Þ=F tð Þ
considering that: V(0)*C(0)=V(t)*C(t) and C(0)/C(t)=F(0)/F(t),
where V(t) is the cell volume at time point t; V(0) is the cell volume
before treatment; F(t) is the ﬂuorescence intensity of calcein at time
point t: F(0) is ﬂuorescence intensity of calcein before treatment;
C(t) is the calcein concentration at time point t, C(0) is the calcein
concentration before treatment. A comparison of two methods for
measuring cell volume revealed no signiﬁcant difference between
the two.
2.7. Immunohistochemistry
Mice were anesthetized with pentobarbital (0.5 ml/kg i.p.; Eutha
77®; Essex Pharma GmbH, München) and then transcardially per-
fused with physiological salt solution followed by 4% paraformalde-
hyde (pH 7.4). The lumbal DRGs and TGs were quickly removed,
postﬁxed with paraformaldehyde, cryoprotected in 30% sucrose, em-
bedded in OCT compound (Ted Pella, Inc., Redding, CA), frozen, and
sectioned on a Microm HM550 cryostat (Zeiss, Oberkochen, Germany).
Sections of 10-μm thickness were cut and mounted on SuperFrost
glass slides (Thermo Fisher Scientiﬁc, Waltham, MA). TG and DRG sec-
tions were circled with a water-resistant pen (DakoCytomation A/S,
Glostrup, Denmark) and pre-treated with a blocking solution of 0.1%
Triton X-100 and 1% donkey serum (Sigma-Aldrich) in PBS for 1 h.
Then slides were co-incubated with a mix of rabbit anti-mouse TRPV1
antibody (1:1000, Genetex, San Antonio, USA) and goat anti-CR anti-
body CG1 (1:300, SWant, Bellinzona) in PBS overnight at 4 °C. After
washing with PBS, sections were incubated with Cy3-conjugated don-
key anti-rabbit IgG (1:500, Jackson, USA) and Alexa-488-conjugated
donkey anti-goat IgG (1:2000, Jackson) for 2 h at 37 °C. Slides were
counterstained with 10 μg/ml DAPI (Invitrogen) in Tris-buffered saline
for 10 min, andmountedwith Hydromount solution (National Diagnos-
tics, Atlanta, GA). Stained slideswere photographed using a confocalmi-
croscope DMI6000 integrated to a TCS-SP5 workstation (Leica).
2.8. Western blotting
Protein samples were isolated from either cell lysates, rat or
mouse tissue. Freshly excised rat or mouse trigeminal ganglia (TG)
or dorsal root ganglia (DRG) were frozen in liquid nitrogen and ho-
mogenized in extraction buffer (10 mM Tris, pH 7.4, 2 mM EDTA,
1 mM β-mercaptoethanol) containing a cocktail of different protease
inhibitors (Roche, Mannheim, Germany). Extraction buffer was also
added to the trypsinized cells and then the soluble proteins were
extracted by ultrasonication for 3×20 s. The suspension was centrifuged
(12,000g, 4 °C, 20 min). Protein concentration in the supernatantwas de-
terminedwith the Bradford protein assay (Bio-Rad,Hercules, CA). Protein
(0.3 μg) fromeach cell culture sample, 10 μg protein fromTGandDRG, as
well as 200 ng of puriﬁed CR were loaded on SDS-polyacrylamide gels
(10%). After separation, proteins were transferred onto nitrocellulose
membranes. After blocking with 5% fat milk powder the nitrocellulose
membrane was treated overnight with rabbit anti-CR primary antibody
diluted at 1:10,000. Appropriate secondary antibodies linked to horserad-
ish peroxidase (Sigma-Aldrich) were diluted at 1:10,000. For the
detection, a chemiluminescent reagent Luminata Classico Substrate
(EMD Millipore Corporation, Billerica, MA, USA) was used. Chemilumi-
nescent and normal illumination digital images were recorded on a sys-
tem from Cell Biosciences (Santa. Clara, CA, USA).
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2.9. Membrane integrity measurements
Cells were seeded on 24-well plates at 50% conﬂuence. Cells were in-
cubated in one of the following solutions: 1) DPBS; 2) DPBS with CAPS
(5 μM); 3) low Ca2+ solution with CAPS (10 μM) and EDTA (10 μM);
4)NMDGsolution andCAPS (10 μM); 5) DPBS+CAPS (10 μM)+RuRed
(10 μM). After 90 min, cells were incubated with 1 μM propidium io-
dide (necrotic cell marker) and 1 μM Hoechst33342 to label all nuclei
for 30 min. Pictures were taken with a Leica DMI 6000B ﬂuorescence
microscope. Cells with red and blue nuclei were counted and the ratio
red/blue was calculated.
2.10. Cytotoxicity and caspases-3/7 activity measurements.
The ApoTox-Glo™ Triplex assay (Promega, Madison, WI, USA) was
used to measure the activity of dead cell proteases and caspase-3/7 en-
zymes. TRPV1/NIH3T3 cells were seeded in black and white 96-well
plates (Thermo Scientiﬁc, Roskilde, Denmark) at a density of 10,000
cells/well. After 2 and 4 h of CAPS exposure, the reagents were added
and cells incubated for 30 min. The luminescence and theﬂuorescent in-
tensity (at 485 nm excitation and 535 nm emission) were monitored
with a Victor X3 2030 Multilabel Reader (Perkin Elmer, Waltham,
Massachusetts).
Fig. 1. Localization of TRPV1 and CR in DRG and TG neurons. A. Immunostaining shows TRPV1-positive (red) and CR-positive (green) neurons in the mouse DRG. To better identify
individual neurons, nuclei were counterstained with DAPI (blue). Yellow arrows point to neurons expressing both TRPV1 and CR evidenced by the yellow color in the merged pic-
ture. Scale bar: 50 μm. B. Pie charts show the distribution of TRPV1- and CR-positive neurons in DRG (left) and TG (right). Approximately 7–8 non-consecutive slices were evalu-
ated. C. Western blot analysis reveals the presence of CR (30 kDa) in rat andmouse TG and DRG tissue, and the fusion protein eGFP-CR (59 kDa) in samples from transfected NIH3T3
and HeLa cells. The upper band (60 kDa) in the sample of recombinant human CR used as a standard is a dimer resulting from long storage of puriﬁed CR as described before for
other CaBPs [32].
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3. Results and discussion
3.1. CR is expressed in a subset of TRPV1-positive DRG and TG neurons
We ﬁrst investigated the expression of CR in peripheral nerve
cells, in particular in dorsal root ganglion (DRG) and trigeminal
(TG) neurons. In the mouse TG, CR-immunoreactive (CR-ir) neurons
were of predominantly large and medium body size (~20% of the
total neurons), while TRPV1-ir neurons were mainly small or
medium-sized neurons (~35% of total neurons); double labeling
was relatively rare and was observed in approximately 6% of neurons.
About 27% of CR-ir neurons were also immunoreactive for TRPV1 and
18% of the TRPV1-ir neurons showed CR expression (Fig. 1A and B).
The relative distribution of the 2 proteins in the DRG was similar;
about 36% of CR-ir neurons co-expressed TRPV1 protein and 24% of
the TRPV1-ir showed CR expression (Fig. 1A and B). Qualitatively sim-
ilar immunohistochemistry results were also observed in rat TG and
DRG neurons (data not shown). In mouse and also rat TG and DRG tis-
sue, CR was expressed as evidenced by Western blot analysis
(Fig. 1C). A protein band of approx. 30 kDa co-migrating with recom-
binant human CR was present in all samples. The weaker CR bands in
mice tissue might have two reasons: I) excision of DRG and TG tissue
in rat is more precise, thus less dilution by CR-negative surrounding
tissue and II) CR expression levels in rat DRG and TG neurons might
be higher than in mouse neurons.
The presence of CR in a sub-population of pain-sensing neurons
has been reported before [40,41]; nociceptors-expressing neurons
were identiﬁed by the presence of pain-related peptides, tachykinins.
In the rat DRG, 7.2% of CR-ir neurons were tachykinin-ir and in the TG,
a larger proportion of CR-ir cells (38.4%) showed tachykinin expres-
sion [41]. In this study, we identiﬁed the pain-sensitive neurons by
TRPV1 immunohistochemistry. The distribution pattern of CR and
TRPV1 in sensory ganglions was rather similar. This is not surprising,
considering that TRPV1 strongly co-localizes with tachykinins, such
as substance P [42] or with the tachykinin receptor NK1 [43].
3.2. Effects of CAPS on cultured DRG neurons
First, we investigated the effect of CAPS on increases in [Ca2+]i
and cell morphology in cultured embryonic rat DRG neurons. Upon
CAPS administration, about 40% of neurons showed a marked in-
crease in [Ca2+]i characterized by the green and yellow color in
Fig. 2A and [Ca2+]i levels remained elevated until the end of the re-
cording period (Fig. 2A and B). These cells correspond to the
TRPV1-ir neurons as previously conﬁrmed by others [4]. Most of the
remaining neurons did not show any changes in [Ca2+]i, however
some cells exhibited CAPS-independent oscillations of [Ca2+]i. The
CAPS-responsive cells also showed morphological changes. Some
neurons became appreciably swollen, retracted their axons and then
“exploded,” i.e. losing the membrane integrity (Fig. 2A). Along some
neuronal processes, membrane blebs appeared suggesting that actin
attachment sites between the plasma membrane and the underlying
cytoskeleton may be weakened by CAPS treatment (Fig. 2A).
At least two types of membrane blebs occurring during biological
processes including cell movement, viral infections, cell division and
cell death have been described [44]. The ﬁrst one called “apoptotic
blebs” is seen during apoptosis, cell division or cell movement;
blebs are small, short-lived (few minutes) and they can retract. In
contrast, necrotic blebs are large and translucent; their size increases
over long periods of time, they cannot retract [44], are independent of
actomyosin contraction [45] and their growing is based on the inﬂux
of ions and water [39]. Although CAPS-induced blebs along DRG neu-
ron processes were small, they did not retract and grew continuously
during the observation period indicative of necrotic blebs. In rat
DRG neurons, similar ﬁndings were reported before, e.g. after RTX
administration, [46] and in mouse neocortical neurons upon NMDA-
receptor (over)activation [47].
3.3. Effects of CAPS on TRPV1-expressing NIH3T3 cells
To get a better mechanistic insight into the processes leading to
the observed CAPS-induced, likely TRPV1-mediated changes in DRG
neurons, we used as a model NIH3T3 cells with or without TRPV1 ex-
pression, thus allowing to selectively investigate the role of TRPV1.
While TRPV1/NIH3T3 cells exposed to CAPS (5 μM) showed a rapid
increase in [Ca2+]i that persisted during the recording period of
15 min, control NIH3T3 did not respond to CAPS application (Fig. 3A
and B). After the rapid elevation of [Ca2+]i within the ﬁrst minute
of CAPS application, [Ca2+]i levels later on were more variable, but
on average stayed around values reached shortly (b2 min) after
CAPS application (Fig. 3B). Resulting from CAPS application, cell
roundening and swelling, as well as the appearance of membrane
blebs was evident selectively in TRPV1/NIH3T3 cells (Fig. 3A). Cell
swelling was quantitatively analyzed: a constant increase in cell
volume reaching approximately 200% after 10 min was observed
(Fig. 3C). The morphology of NIH3T3 control cells was indistinguish-
able from untreated cells (data not shown). Thus, in all further exper-
iments, NIH3T3 cells were used as a negative control, although a
small CAPS-dependent increase of [Ca2+]i in a subclone of NIH3T3
cells has been reported before [48]. In our hands NIH3T3 cells were
Fig. 2. TRPV1-mediated toxicity in cultured rat DRG neurons in vitro. A. Time-lapse mi-
croscopy shows primary DRG neurons loaded with the Ca2+ indicators Fluo-3/FuraRed.
Cells with basal (low) [Ca2+]i show orange/red color. After CAPS (5 μM) administra-
tion, approximately 40% of primary DRG neurons (examples marked with white aster-
isks) display an increase in [Ca2+]i evidenced by yellow/green color (upper row). Scale
bar: 25 μm. Two sequential images show DRG neurons after 10 μM CAPS exposure. The
membrane integrity of the neuron marked with a red arrow was likely impaired and the
cell was bursting/exploding (necrotic cell death, lower row—left side). Scale bar: 10 μm.
Yellow arrows demonstrate membrane blebs along the axons (lower row—right side).
Scale bar: 10 μm. B. Time course of changes in the Fluo-3/FuraRed ratio in DRG neurons.
CAPS caused a rapid increase in [Ca2+]i in CAPS-responsive cells. Data aremean±standard
deviation (S.D.) from 10 cells. The experiment was repeated three times.
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non-responsive to CAPS treatment. Blocking of the functional TRPV1
channels in the plasma membrane by the membrane-impermeant
RuRed inhibited cell swelling (Fig. 3C) except in a very few cases
and considerably decreased the CAPS-evoked increase in [Ca2+]i
(Fig. 3B). The remaining much smaller Ca2+ signal (Fig. 3B) was
caused by the CAPS-mediated activation of TRPV1ER, since the lipo-
philic properties of CAPS allows it to cross the plasma membrane
and to act on TRPV1ER. The TRPV1ER-mediated elevation in [Ca2+]i
are rather small: from 50 nM to approx. 100 nM [49,50] at zero extracel-
lular [Ca2+]o. Of importance the small elevation in [Ca2+]i after CAPS ap-
plication in the presence of RuRed did not cause the cells to swell, i.e. to
increase their volume (Fig. 3C). As the TRPV1/NIH3T3 cells showed sim-
ilar morphological and intracellular [Ca2+]i changes in response to CAPS
application compared with the cultured DRG primary neurons, we used
TRPV1/NIH3T3 cells for further experiments aimed to delineate the
CAPS-induced mechanisms leading to swelling and cell death.
In cortical neurons, bleb formation, more precisely an increase in
the size of varicosities was suggested to be caused by NMDA receptor
activation leading to accumulation of excess [Ca2+]i, which in turn
causes activation of calpain, a Ca2+-dependent protease [47]. Howev-
er, no calpain activation was seen in DRG neurons treated with RTX,
despite clear elevations in [Ca2+]i [46]. A crucial role of Na+ inﬂux
in bleb formation on inner hair cells appearing during the isolation
process of the organ of Corti was shown [51] and in hepatocytes,
cell swelling evoked by free-radical exposure was attenuated in
cells, whose Na+ pump was inhibited with ouabain [52]. Finally,
blocking a non-identiﬁed non-selective cation channel by ﬂufenamic
acid, inhibiting stretch-activated cation channels by Gd3+ or replace-
ment of extracellular Na+ with NMDG was also effective against
free-radical induced necrosis in hepatocytes [39]. Thus, in the next
series of experiments we investigated the effect of Na+ ions on
CAPS-mediated cell morphology alterations.
3.4. Na+ inﬂux through the TRPV1 channel
The TRPV1 channel is a non-speciﬁc cation channel permeable for
Ca2+ ions, but also for Na+ ions [4]. Channel opening by CAPS causes
an increase in [Ca2+]i from 0.1 μM up to 0.5–1 μM [49] and an in-
crease in [Na+]i from 5 mM up to 40 mM [53]. Since Na+ is the
major extracellular osmolyte and [Na+]i shows the largest absolute
change in intracellular concentrations upon TRPV1 activation, we ﬁrst
investigated the involvement of Na+ overload in membrane blebbing.
Measuring [Na+]i with the indicator CoroNa-Green showed a rapid in-
crease in [Na+]i in TRPV1/NIH3T3 cells immediately after CAPS adminis-
tration (Fig. 4A); [Na+]i remained elevated during the recording period
of 15 min, similar to the increase in [Ca2+]i shown in Fig. 2B. In the ab-
sence of extracellular Na+, cell swellingwas blocked, demonstrating the
pivotal role of an increase in [Na+]i in this process (Fig. 4B). The addition
of Na+ (73 mM) to the extracellular solution 15 min after CAPS applica-
tion resulted in an increase in [Na+]i (Fig. 4D), while [Ca2+]i remained
unchanged (Fig. 4C). The increase in [Na+]i in the extracellular solution
evokedmorphological changes; mainly membrane bleb formation rath-
er than cell swelling (Fig. 4B).
In a previous study it was concluded that increased [Ca2+]i and
not [Na+]i was the main determinant for TRPV1-mediated cytotoxic-
ity [54]. The conclusions were based on the fact that application of the
TRPV1 antagonists capsazepine or RuRed several minutes after CAPS
application decreased [Ca2+]i, but did not reverse the elevated
[Na+]i in experiments lasting for up to 5 min. When monitoring cell
death in TRPV1-transfected HEK293 cells 12–15 h after continuous
CAPS exposure, cells treated with RuRed showed less cell death
evidenced by propidium iodide uptake. In our view, these results do
not preclude a role for Na+ ions. The decrease in [Na+]i to basal levels
might take much longer for CAPS-treated TRPV1-expressing HEK293
[54] or NIH3T3 cells (our study). We did not determine how long it
would take for [Na+]i to reach basal levels after CAPS removal in
TRPV1/NIH3T3 cells. However, also in neurons recovery from in-
creased [Na+]i is rather slow, in parallel to the rather long periods re-
quired for the retraction of transient membrane blebs. In cortical
neurons it takes 2 h to revert blebs after removal of the glutamate re-
ceptor agonist NMDA [47]. Also neuronal cell swelling caused by ve-
ratridine, an activator of a voltage-gated Na+ channels persisted for
90 min after drug removal [38].
3.5. Increasing [Ca2+]o promotes Na
+ inﬂux through TRPV1 channel
In the next series of experiments, we investigated the role of [Ca2+]o
on theCAPS-mediated effects. In the absence of extracellular [Ca2+]o cell
swelling (volume increase) was much slower and also the magnitude
wasmuch smaller 10 min after CAPS application (Fig. 5A) in comparison
to [Ca2+]o of 1 mM depicted in Fig. 3C. The small increase in [Ca2+]i
resulting from TRPV1ER-mediated ER Ca2+ release was of similar
Fig. 3. TRPV1-mediated toxicity in TRPV1/NIH3T3 cells. A. Time-lapse microscopy im-
ages show TRPV1-expressing NIH3T3 cells loaded with intracellular Ca2+ indicators
exposed to CAPS (5 μM). TRPV1/NIH3T3 cells show a rise in [Ca2+]i, (change from
orange/red to yellow/green), swelling of the cell body, retraction of protrusions and
membrane blebbing at 15 min (yellow arrows). Scale bar: 25 μm. B. Time course of
changes in Fluo-3/FuraRed ratio signal in NIH3T3 cells with or without expression of
TRPV1. CAPS causes an increase in [Ca2+]i in TRPV1-expressing cells that is mostly
prevented by pretreatment (pret.) of cells with RuRed, a blocker of plasmalemmal
TRPV1. C. Cell volume increase caused by CAPS administration, which is prevented by
RuRed. Data in B and C are mean±S.D. from 10 cells. Diagrams are representative of
3 separate experiments showing similar results.
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magnitude as observed after blocking of plasma membrane TRPV1 by
RuRed (Fig. 3B). Increasing [Ca2+]o to 0.5 mM resulted in a rapid in-
crease in [Ca2+]i (Fig. 5B) and concomitantly to an increase in cell vol-
ume (Fig. 5A). However, no membrane bleb formation was observed.
Measuring the [Na+]i increase upon TRPV1 activation revealed that
[Na+]i elevations were clearly slower in the absence of extracellular
Ca2+ ions (Fig. 5C).
These results suggest that although Na+ inﬂux via TRPV1 channels
is the main contributor to the cell volume increase, Ca2+ ions modu-
lating the function of TRPV1 also participate in the cell swelling pro-
cess. The increased Na+ inﬂux rate in the presence of extracellular
Ca2+ is the likely result of an increased permeability for Na+ across
the TRPV1 channels, and not by an increased driving force. As our ex-
periments started at resting potential, the initial Na+ driving force
should be the same, independent of [Ca2+]o. Thus, the presence of ex-
tracellular Ca2+ ions might evoke its modulating effect on Na+ inﬂux
in at least two ways: I) modifying the TRPV1 pore size to make it
more suitable for Na+ transport or II) increasing the open-state prob-
ability of TRPV1 channels.
A role for increased [Ca2+]i in membrane bleb formation was pre-
viously provided in experiments using the TRPV1 agonists CAPS and
the more potent RTX. In DRG neurons, the latter caused a six-fold
higher membrane loss (bleb formation) compared to CAPS; this in-
crease was due to longer lasting elevations in [Ca2+]i in the presence
of RTX, while the maximum increase in [Ca2+]i evoked by short RTX
treatment was not different from the one induced by CAPS [6]. Thus,
the authors concluded that “the prolonged elevations in [Ca2+]imay po-
tentiate RTXs toxicity.” Ionic currents through TRPV1 channels are dif-
ferent at higher [Ca2+]o: the reduction in the ratio of Ca2+ and Na+
ion permeability (PCa/PNa) is the consequence of prolonged activation
of TRPV1 channels, which causes activation-evoked modiﬁcations in
the TRPV1 pore structure [55]. At low [Ca2+]o, TRPV1 channels show a
time-dependent increase in the PCa/PNa ratio. In other words, high
[Ca2+]o renders TRPV1 channels more permeable to Na+ ions than to
Ca2+ ions and these results are consistent with our data.
3.6. Increase in [Ca2+]i activates/sensitizes TRPV1 channels
To test the hypothesis that increased [Ca2+]i sensitizes/activates
TRPV1 channels, we increased [Ca2+]i by either IONO or thapsigargin.
In control NIH3T3 cells IONO caused a transient peak of [Ca2+]i last-
ing for approx. 2 min; however [Ca2+]i levels did not completely re-
cover to pre-IONO conditions (Figs. 6B and 7A). IONO makes the
plasma membrane leaky to Ca2+ ions and additionally promotes
Ca2+ release from internal stores [56]. Thus, the ﬁrst transient peak
observed immediately after IONO addition is caused by ER Ca2+ re-
lease, while the later phase is governed by IONO-mediated, IONO
concentration-dependent plasma membrane Ca2+ inﬂux [57]. The
decrease in [Ca2+]i was the likely result from increased Ca2+ extrusion
and/or organellar Ca2+ uptake, because no changes inmembrane integ-
rity evidenced by propidium iodide exclusion were observed (data not
shown).
In TRPV1-expressing NIH3T3 we could distinguish two cell sub-
populations based on their response to IONO. In the ﬁrst population
(p1), IONO caused a single Ca2+ peak similar to that seen in control
NIH3T3 cells (Fig. 6B). In p1 cells CAPS administration 4 min after
IONO treatment evoked a second, robust [Ca2+]i increase (Fig. 6B).
In the second population (p2), [Ca2+]i remained elevated after IONO
treatment and the sequential CAPS administration resulted in an addi-
tional, but rather minor increase in [Ca2+]i (Fig. 6B). The proportion of
the p2 subpopulation ranged from24% to 55% in individual experiments.
A likely explanation for the different effects seen in p1 and p2 cells is
possibly linked to different TRPV1 expression levels and/or IONO sensi-
tivity. We hypothesize that only in p2 cells IONO-induced elevations in
[Ca2+]i were sufﬁcient for robust TRPV1 activation and thus addition
of CAPS had a minor additional effect. Upon IONO treatmentmembrane
Fig. 4. Effect of Na+ ions on cell swelling A. Application of CAPS (5 μM) causes a lasting increase in [Na+]i in TRPV1-expressing cells. B. Images from time-lapse video reveal mor-
phological changes of TRPV1/NIH3T3 cells. The low Na+ media was replaced by one containing 73 mM Na+ 14 min after CAPS administration. Membrane blebs (arrows on the
image taken at 29 min) were evident only after increasing [Na+]o and not during the ﬁrst 15 min of CAPS application at low [Na+]o. C. An increase in [Ca2+]i after CAPS adminis-
tration occurred at low [Na+]o, and did not further increase when switching to 73 mM [Na+]o. D. Increase in [Na+]i after increasing [Na+]o to 73 mM in cells pretreated with CAPS
at “zero” [Na+]o. All graphs depict results from 10 cells (mean±S.D.). One representative experiment out of three is shown.
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blebs appeared only in TRPV1/NIH3T3-p2 cells, while control NIH3T3
and p1 cells did not show any morphological changes again indicating
that high [Ca2+]i is required and sufﬁcient to activate TRPV1 channels
that led to an increase in cell volume and bleb formation (Fig. 6A).
The above results were further validated in control NIH3T3 and
TRPV1/NIH3T3cells by cobalt accumulation experiments. Treatment
with CAPS (5 μM) or IONO (5 μM) resulted in a robust or minor cobalt
accumulation in TRPV1/NIH3T3 cells, respectively (Fig. 6C). The CAPS-
induced precipitate could be prevented by RuRed (not shown). In the
absence of CAPS or IONO, but incubation with the cobalt solution,
TRPV1/NIH3T3 cells showed no brownish cobalt precipitate (Fig. 6C).
In control NIH3T3 cells, the addition of CAPS and IONO did not result
in cobalt accumulation (Fig. 6C).
A similar effect has been previously reported in DRG neurons: the
CAPS-mediated increase in [Ca2+]i was about twofold larger when
CAPS was added shortly after addition of thapsigargin, [6] and also
Ca2+ mobilization by carbachol led to TRPV1 activation [58]. We hy-
pothesize that TRPV1 can sense elevated [Ca2+]i by an intracellular
Ca2+ sensor domain or in cooperation with a Ca2+ sensor protein.
Other members of the TRP superfamily are candidates for the store-
operated Ca2+ channels that are activated by elevated [Ca2+]i due
to ER depletion [59]. In the case of TRPC1, the Ca2+ sensor protein
STIM1 transmits the elevated [Ca2+]i signal to the channel [60].
3.7. Calretinin modulates Ca2+ signals in NIH3T3 and TRPV1/NIH3T3 cells
Since CR is expressed in a sub-population of TRPV1-ir neurons, the
role of CR in CAPS-mediated cell morphology changes was analyzed
in the NIH3T3 model system using control NIH3T3 cells, TRPV1/
NIH3T3 cells and additionally in HeLa cells, all of which showed no
endogenous CR expression evidenced by Western blot analysis
(Fig. 1C). In order to directly assess relative CR expression levels we
used constructs coding for fusion proteins consisting of either eGFP
or mRFP as the N-terminal part followed by full-length CR as the
C-terminal part. Stably eGFP-CR expressing clones were established
by lentivirus infection of the above cell lines, followed by cloning by
limiting dilution. Testing of CR protein expression in selected clones
revealed the clones to contain considerable amounts of CR (Fig. 1C).
Sufﬁciently high CR expression levels were considered as a requirement
in order to detect changes in CR-expressing and non-expressing clones,
since also theCa2+ indicator dyes act as Ca2+ buffers. Cellswith orwith-
out CR expression were mixed, plated on coverslips and analyzed with
respect to Ca2+ signaling. Recordings from the green channel allowed
to distinguish CR-expressing from non-expressing cells, while simulta-
neously recording [Ca2+]i with FuraRed detected on the red channel.
There was no interference between the two channels. The eGFP-CR
and control cells were undistinguishable on the red channel under
basal conditions. Moreover, comparing the IONO-evoked [Ca2+]i trace
in NIH3T3 cells with or without eGFP (without the CR part) showed
that eGFP alone does not modify Ca2+ signals (data not shown).
CR decreased the maximal amplitude of [Ca2+]i as previously ob-
served in other CR-transfected cells subjected to glutamate-induced
elevations in [Ca2+]i [34]. However, the kinetics of the recovery
phase ([Ca2+]i decay) was clearly slowed down, both in NIH3T3
(Fig. 7A) and HeLa cells (not shown) after IONO administration. The
effect of CR on CAPS-induced elevations in [Ca2+]i are shown in
Fig. 7B. First, we observed that the initial rise in [Ca2+]i within the
ﬁrst 30 s after CAPS administration was slower in CR-expressing cells.
Moreover, themaximal value during theplateauphase remained always
lower in eGFP-CR/TRPV1/NIH3T3 cells than in TRPV1/NIH3T3 cellswith-
out CR expression (Fig. 7B). In parallel, the increase in volumewas clear-
ly smaller in the CR-expressing cells (Fig. 7C) and also bleb formation
was less pronounced (data not shown). Along the same line, also the
CAPS-induced increase in [Na+]i in cells expressingmRFP-CRwas signif-
icantly lower just shortly after CAPS application, at later time points
(>1 min after CAPS treatment) these difference disappeared (Fig. 7D).
Nonetheless, the CR-provoked decrease in cell volume persisted for at
least 15 min (Fig. 7C). This indicates that the relative small difference
in maximal [Ca2+]i after CAPS application in the presence of CR
translates into a relative large effect with respect to cell swelling and as-
sociated volume increase, despite minor effects on [Na+]i. Our results
suggest that CR evokes its effect by its Ca2+-buffering function, limiting
the maximal amplitude of CAPS-mediated increase in [Ca2+]i. However,
we cannot exclude the possibility that CR might also modulate TRPV1
activity via an interaction with other proteins affecting TRPV1 channel
function or directly with the TRPV1 channel. We have summarized the
molecular mechanisms underlying the cell swelling caused by prolonged
TRPV1 activation in the scheme shown in Fig. 8.
Fig. 5. Effect of Ca2+ ions on cell swelling A. Low [Ca2+]o strongly attenuated and
slowed down cell swelling. Relative cell volumes (n=10 cells) were evaluated by the
video imaging method. Media containing Ca2+ (0.5 mM ﬁnal concentration) was ad-
ministered 15 min after CAPS exposure. One representative experiment out of three
is shown. B. In the absence of [Ca2+]o, the increase in [Ca2+]i after CAPS application
was rather small, in comparison to the increase in [Ca2+]i observed after rising
[Ca2+]o to 0.5 mM. Data in B. and C. are mean±S.D. from 10 cells. One representative
experiment out of three is shown. C. The rate in rise of [Na+]i was slower in “zero”
[Ca2+]o, but plateau levels of [Na+]i reached after approx. 90 s were similar. The traces
on the graph show average values from seven individual experiments. Asterisks indi-
cate signiﬁcant differences (pb0.05).
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Fig. 6. Elevated [Ca2+]i sensitizes/activates TRPV1 receptors. A. Time-lapse confocal images show the effect of IONO on NIH3T3 cells with (upper row) orwithout TRPV1 expression (lower
row). Several TRPV1/NIH3T3 cells show a rise in [Ca2+]i, cell swelling andmembrane blebs (yellow arrows) after addition of IONO (3 μM). Scale bars: 25 μm. B. IONO application leads to a
transient increase in [Ca2+]i in control NIH3T3 cells (n=10 cells) and in a subpopulation (p1) of TRPV1-expressing cells (n=10 cells). The application of CAPS (5 μM) 4 min later induces a
strong [Ca2+]i increase in p1, but not control cells. In the second sub-population p2, [Ca2+]i remains elevated after IONO treatment and addition of CAPS has amuch smaller effect resulting
in only a small additional increase in [Ca2+]i. One representative experiment out of three is shown. C. Cobalt histochemistry reveals the function of plasmalemmal TRPV1 after CAPS or IONO
treatment in TRPV1/NIH3T3 (upper row) and in control NIH3T3 cells (lower row). Scale bar: 50 μm. D. TRPV1-expressing NIH3T3 cells show increased [Ca2+]i upon thapsigargin (2 μM )
treatment, possibly caused by partial TRPV1 activation. Data are mean±S.D. from 10 cells and the graph is representative for 3 separate experiments showing similar results.
Fig. 7. The effect of CR on NIH3T3 cells with or without TRPV1 expression. A. The presence of eGFP-CR (CR) modulates IONO-induced [Ca2+]i transients: CR decreases the peak am-
plitude in [Ca2+]i, but slows down recovery of [Ca2+]i. B. The CAPS-induced rise in [Ca2+]i is slower in NIH3T3/TRPV1 cells and the maximal amplitude is lower in CR expressing
cells. C. CR expression diminishes the CAPS-induced volume increase. D. In cells expressing mRFP-CR, the CAPS-induced [Na+]i elevation in NIH3T3/TRPV1 cells is slowed down. In
all cases, data are mean±S.D. from 10 cells. Graphs are representative of 3 separate experiments showing similar results. Asterisks indicate signiﬁcant differences (pb0.05).

ht
tp
://
do
c.
re
ro
.c
h
A role of Ca2+-binding proteins in conferring resistance to Ca2+
overload has been demonstrated in several systems. Calretinin-
expressing neurons were relatively spared after exposure to either
NMDA, glutamate or Ca2+ ionophore [33]. The expression of calretinin
also protectedN18-RE 105 neuroblastoma-retina hybridN18 cells against
excitotoxic cell death [35]. Calretinin delayed the onset of cell death after
excitotoxic stimulation in transfected P19 cells [34]. In Huntington's dis-
ease, where the excitotoxic effect of glutamatergic striatal inputs originat-
ing from the thalamus and cerebral cortex might play a role in disease
progression, the calretinin-positive interneurons were preferentially
spared [61].
3.8. Prominent Na+ inﬂux contributes to CAPS-induced TRPV1-mediated
cell death
To demonstrate that the fast cell-killing effects of high doses
(10 μM) of CAPS is based on its ability to induce efﬁcient and promi-
nent Na+ and water inﬂux with which TRPV1-expressing NIH3T3
cells cannot cope, we measured the cell membrane integrity under
different conditions. In TRPV1/NIH3T3 cells CAPS-treated under
control conditions, approximately 50% cells stained positive for
propidium iodide (PI) (Fig. 9A). A signiﬁcant decrease in the propor-
tion of impaired (PI-positive) cells was encountered in the presence
of RuRed or the absence of either Ca2+ or Na+ ions in the extracellu-
lar medium. Moreover, cells expressing calretinin were also protected
to the same degree as cells treated with the TRPV1 inhibitor RuRed or
cells subjected to CAPS treatment in the absence of extracellular Ca2+
or Na+ ions. NIH3T3 cells without TRPV1 expression were not sensi-
tive to CAPS-induced cytotoxicity (Fig. 9A).
Finally, we investigated the mechanism leading to CAPS-mediated
cytotoxicity by simultaneously analyzing the activity of dead cell pro-
teases, markers for necrotic cell death and caspase-3/7, markers for
apoptosis. Based on the previous experiments, we hypothesized a
CAPS-induced mostly necrosis-like process. Two and four hours of
CAPS treatment resulted in concentration-dependent increase in
markers of necrosis, while no evidence for caspase-3/7 activation, a
marker for the intrinsic apoptosis pathway, was observed (Fig. 9B).
Acute cytotoxicity was seen only at higher CAPS concentrations, 5
and 50 μM.
The cellular and molecular mechanisms underlying the CAPS-
induced neural loss are still unresolved. Evidences for CAPS-induced
neuronal cell death by apoptosis with caspase activation have been
reported [62,63], while some studies state that it is an apoptosis-
like, but caspase-independent process [64,65]. Yet other studies
doubt the process to be apoptosis at all [5,46]. It is very likely
that several mechanisms might play a role in TRPV1-mediated tox-
icity also depending on the cell type and moreover on the experi-
mental protocol.
An essential role for Ca2+ ions in the extracellular milieu for
CAPS-induced cytotoxicity has been reported before [54] and was
also conﬁrmed in our study. Moreover, we demonstrated the pivotal
role of Na+ inﬂux; our data show that CAPS treatment for 2–4 h
causes a loss of membrane integrity typical for necrosis loss due to
prominent Na+ and water inﬂux (Fig. 8). We suggest that this mainly
occurred in those cells, where the TRPV1 surface density is high. This
might then be followed by an apoptotic process, in which the contin-
uously elevated [Ca2+]i and possibly the resulting mitochondrial
Ca2+ overload might trigger the apoptotic events as shown before
[66]. When CAPS is applied at very high, millimolar concentrations,
it can cause TRPV1-independent cell death [67]. Under these condi-
tions CAPS replacing quinone in the mitochondrial respiratory chain
inhibits energy production that ﬁnally leads to apoptosis. However,
this was certainly not the case in our study, where in most experi-
ments 5 μM CAPS was used.
Fig. 8. Proposed model for the molecular mechanism of cell swelling induced by
prolonged TRPV1 activation. The cell swelling is the consequence of Na+ inﬂux via ac-
tivated TRPV1 channels and concomitant H2O transport. The presence of extracellular
Ca2+ ions might evoke its positive modulating effect on Na+ inﬂux in at least two
ways: i) modifying the TRPV1 pore size to make it more suitable for Na+ transport
or ii) increasing the open-state probability of TRPV1 channels by elevation of [Ca2+]i.
Besides the well-known TRPV1 agonist CAPS, an elevation of [Ca2+]i by the Ca2+ ion-
ophore ionomycin (IONO) or other factors can also activate/sensitize TRPV1 channels.
This effect can be blocked by the addition of the membrane impermeant Ruthenium
Red (RuRed). The presence of CR in the cytosol blunts peak [Ca2+]i and eliminates/de-
creases the TRPV1 activation mediated by an increase in [Ca2+]i. Whether the effect of
CR is solely the result of CR's Ca2+-buffering properties or indirectly mediated by bind-
ing to a TRPV1-modulating protein or directly to TRPV1 channels remains to be deter-
mined. Positive modulation of TRPV1 is marked by “+,” negative modulation/
inhibition by “−.” Solid arrows show experimentally proven regulation and the dashed
arrow indicates hypothetical modulation of TRPV1 (e.g. by CR).
Fig. 9. Cell swelling impairs membrane integrity and leads to necrotic cell death. A. In
control NIH3T3 cells, the addition of CAPS (10 μM) in DPBS solution does not signiﬁ-
cantly decrease the proportion of intact (propidium iodide-negative) cells, while this
ratio is decreased to less than 50% in TRPV1/NIH3T3 cells 2 h after CAPS application.
All of the following “treatments” prevent/diminish loss of membrane integrity:
blocking of plasmalemmal TRPV1 with RuRed, expression of CR, CAPS treatment in
“zero” [Ca2+]o or “zero” [Na+]o. Three independent experiments were evaluated.
Data are mean±SD. B. CAPS treatment of TRPV1/NIH3T3 cells for 2 and 4 h results in
a dose-dependent increase in cytotoxicity (necrosis) with no caspase-3/7 (apoptosis)
activation. The experiment was repeated two times.
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4. Outlook
Considering that CR and TRPV1 co-expressing neurons are mainly
medium size Aδ-type neurons, which are involved in fast-pain trans-
mission, we may speculate that these neurons are much more resis-
tant to Ca2+ and Na+ overload induced by repetitive activation of
TRPV1 than the small mainly unmyelinated C-neurons, which are as-
sociated with chronic, dull pain.
The membrane bleb formation of C-ﬁbers could explain the re-
versible reduction in intra-epidermal nerve ﬁbers observed after 8%
CAPS patch application [26]. The signiﬁcant volume increase in senso-
ry axons may result in severing/fragmentation or retraction of axons.
This phenomenon we also observed in vitro on DRG axons and on the
long protrusions of ﬁbroblast cells. Comparing the effect of RTX and
CAPS in different experiments [68], it was reported that although
RTX binds 100,000-fold more effectively to TRPV1 than CAPS [69],
the pungency test showed only a difference by a factor of 10 [70].
We may hypothesize that the RTX-evoked pain sensation and pain
transmission is “reduced,” by the fragmentation/severing of sensory
axons due to the more pronounced membrane loss [46].
The similarities between the TRPV1-mediated neurotoxicity and the
glutamate-receptor-mediated excitotoxicity are conspicuous. In both
cases, ligand-gated channels form a pore for Ca2+ and Na+ ions. The
permeability of TRPV1 to Ca2+ and Na+ (PCa/PNa=9.6) [4] is similar
to values reported for NMDA glutamate receptors (PCa/PNa=10.6)
[71]. The glutamate receptor activation by NDMA also causes mem-
brane bleb formation in cortical neurons [47] andNa+ ions have already
been proposed to be involved in neuronal cell death caused by gluta-
mate receptor agonists [72,73]. Loss of pain-sensing neurons by
TRPV1-mediated overstimulation is usually not a life-threatening situa-
tion, but loss of other neuron populations by excitotoxicity, e.g. motor
neurons or cortical neurons, can cause severe conditions [74]. Because
cell volume regulation is a critical step in both processes, a better under-
standing of the mechanisms of bleb formationmight lead to identifying
the steps involved in the development of excito-/neurotoxicity-related
diseases.
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